Physician Referral Guide: Hyperbaric Oxygen for Thermal Burns | Canada Hyperbarics Skip to main content
Preview - not yet published

This page is hidden from search engines and is not linked anywhere public. It is a review copy.

Physician referral guide

Physician Referral Guide: Hyperbaric Oxygen for Thermal Burns

For referring and emergency physicians in Canada. Severe thermal burn injury is one of the 14 conditions publicly funded in Canada for hyperbaric oxygen therapy (HBOT), and where it is used it is an adjunct to specialised burn-centre...

Updated 2026-06-28 Reviewed quarterly
Download this guide
3 open-access studies, 2020 to presentReviewed every quarterFor Canadian clinicians

For referring and emergency physicians in Canada. Severe thermal burn injury is one of the 14 conditions publicly funded in Canada for hyperbaric oxygen therapy (HBOT), and where it is used it is an adjunct to specialised burn-centre care, not a substitute for resuscitation, surgery, or wound management. Because the burn evidence base is limited and largely observational, this guide is deliberately conservative. It summarises when to consider referral, how to assess and stabilise the patient first, what the evidence does and does not support, the Canadian referral pathway, and contraindications. It closes with the complete list of open-access research published since 2020, each linked to its free full text.

When to refer

HBOT for burns is time-sensitive, so any consideration of adjunctive hyperbaric treatment should happen in parallel with definitive burn-centre referral, not after it. The first priority is always transfer to a burn centre for resuscitation and surgical assessment. Where a hospital-based hyperbaric programme is co-located with or accessible to that burn centre, consider raising HBOT for a patient with:

  • Deep partial-thickness (deep second-degree) burns exceeding roughly 20 percent total body surface area (TBSA), where progression of the zone of stasis threatens otherwise salvageable tissue.
  • Selected full-thickness (third-degree) burns with a significant viable zone-of-stasis component that may benefit from improved tissue oxygenation.
  • Burns to functionally critical sites such as the hands, face, perineum, or major joints, where preserving depth-dependent function changes the reconstructive outcome.
  • Electrical burns with extensive deep-tissue involvement, where surface area understates the true tissue injury.

The biological window matters. Where benefit has been reported, HBOT was generally started within the first 24 hours of injury, and the rationale for benefit is concentrated in the first 24 to 48 hours, when the zone of stasis is most vulnerable to progression. Refer early and let the burn centre and hyperbaric team decide together, rather than waiting to see whether the wound declares itself.

Body diagram with four referral criteria for adjunctive hyperbaric oxygen in thermal burns: deep partial-thickness burns over about 20 percent of total body surface area, selected full-thickness burns with a significant zone-of-stasis component, burns to functionally critical sites such as the face, hands, perineum, and joints where depth dictates reconstructive outcomes, and electrical burns with extensive deep-tissue involvement where surface area understates the injury.
Figure When to refer: adjunctive hyperbaric oxygen is reserved for complex burns that threaten salvageable tissue or a functionally critical site, not routine burns. The presentations to consider are deep partial-thickness burns over roughly 20 percent of total body surface area, selected full-thickness burns with a significant zone-of-stasis component, burns to critical sites such as the face, hands, perineum, or joints where depth drives the reconstructive outcome, and electrical burns whose deep-tissue damage is understated by the surface area. In every case the referral conversation runs in parallel with burn-centre transfer and resuscitation, which always take priority.

Assessing the patient before referral

Burn resuscitation and stabilisation come first. While arranging burn-centre transfer and any hyperbaric discussion, the receiving department should:

  • Secure the airway and assess for inhalation injury. Facial burns, singed nasal hair, carbonaceous sputum, or stridor warrant early airway evaluation. Suspected concurrent carbon monoxide or cyanide exposure changes the urgency and the oxygen strategy and should be flagged explicitly to the hyperbaric team.
  • Begin fluid resuscitation using a recognised formula and titrate to urine output. Haemodynamic stability is a prerequisite for safe chamber entry.
  • Calculate TBSA and document burn depth and distribution with a standard chart, and photograph the wounds where possible.
  • Exclude an untreated pneumothorax on examination and chest imaging, particularly after blast, electrical, or high-energy mechanisms, because it is an absolute contraindication to chamber entry until drained.
  • Record the medication and exposure history, specifically any concurrent bleomycin or disulfiram, and the mechanism, timing, and any associated trauma.
Five-step pre-referral stabilisation sequence shown as chevrons: secure the airway and assess for inhalation injury while flagging carbon monoxide and cyanide exposure; titrate fluid resuscitation to urine output with haemodynamic stability as a prerequisite; map the burn by calculating total body surface area, documenting depth and distribution, and photographing wounds; exclude an untreated pneumothorax with chest imaging; and record the medication history, including bleomycin and disulfiram, and the injury mechanism.
Figure Before referral, stabilise first; burn resuscitation and definitive-centre transfer always supersede hyperbaric coordination. Secure the airway and assess for inhalation injury, flagging carbon monoxide and cyanide exposure. Titrate fluids to urine output, since haemodynamic stability is a prerequisite for chamber entry. Map the burn by calculating total body surface area and documenting depth and distribution, and photograph the wounds. Exclude an untreated pneumothorax on chest imaging, and record the medication history, in particular any bleomycin or disulfiram, together with the injury mechanism. These details let the receiving team decide whether and when hyperbaric oxygen can be added safely.

What the evidence supports

The evidence for HBOT in thermal burns is limited and should be presented to patients and colleagues as such. The condition is graded as moderate-quality evidence drawn predominantly from controlled and observational studies rather than from large, definitive randomised trials.

The most cited synthesis is the Cochrane review (Villanueva et al. 2004), which found the evidence mixed and predominantly observational and did not establish a clear benefit. Observational work, most notably the Cianci case series, has reported associations with reduced oedema, shorter hospital length of stay, fewer skin-grafting procedures, and reduced mortality in patients with moderate-to-severe burns. These are associations from non-randomised data, not proof of benefit, and they should not be framed as established outcomes.

The mechanistic rationale is more secure than the clinical outcome data. At treatment pressure, plasma oxygen content rises roughly 10- to 15-fold and tissue oxygen tension in the peri-burn zone can reach several hundred mmHg, which supports the threatened zone of stasis. Hyperoxic vasoconstriction reduces oedema without compromising oxygen delivery, neutrophil bactericidal activity and antibiotic efficacy are enhanced, and angiogenesis and fibroblast function are supported for wound healing and graft take. Taken together, the biological plausibility is reasonable while the outcome evidence remains modest, so HBOT in burns is best understood as a reasonable adjunct in selected cases rather than a proven intervention.

Balance-scale comparison contrasting robust biological plausibility with moderate-quality observational associations. The plausibility column lists a 10- to 15-fold rise in plasma oxygen, preservation of the zone of stasis, and reduced oedema. The associations column notes the Cochrane review by Villanueva and colleagues in 2004, which found mixed data and no clear benefit, and the Cianci case series, which reported associations with shorter stays, reduced fluid needs, and fewer grafts.
Figure What the evidence supports, framed honestly. The mechanistic rationale is strong: 100 percent oxygen at pressure raises plasma oxygen roughly 10 to 15 fold, which can help preserve the vulnerable zone of stasis and reduce oedema. The clinical evidence is weaker and largely observational. A Cochrane review (Villanueva et al. 2004) found mixed data and no clear benefit, and case series such as those of Cianci report associations with shorter hospital stays, reduced fluid requirements, and fewer grafting procedures rather than proof of cause and effect. Hyperbaric oxygen for thermal burns is therefore best understood as a biologically sound, reasonable adjunct in selected cases, not a definitive or proven treatment.

Clinical translation

Consider it early, position it correctly, and do not oversell it. The rationale for benefit is concentrated in the first 24 to 48 hours, so any decision to involve the hyperbaric team should be made alongside the burn-centre referral, not days later. Where it is offered, a typical course is 100 percent oxygen at 2.0 to 2.4 ATA for 90-minute sessions, often two sessions in the first 24 hours and then once daily for roughly 5 to 14 sessions, with extended courses of up to about 30 sessions reserved for severe burns or staged reconstruction. Throughout, HBOT runs in parallel with surgical and wound-care management and never displaces it. You can read the full clinical background on the acute thermal burns condition page.

Timeline showing hyperbaric oxygen running strictly parallel to primary burn-centre care across resuscitation, surgical assessment, and wound management. The hyperbaric prescription is 100 percent oxygen at 2.0 to 2.4 ATA for 90 minutes: about two sessions in the first 24 hours, then a typical course of 5 to 14 sessions, with up to roughly 30 sessions reserved for severe or staged reconstruction.
Figure Clinical translation: hyperbaric therapy runs strictly parallel to surgical and wound care and never displaces it. A typical prescription is 100 percent oxygen at 2.0 to 2.4 ATA for about 90 minutes, often given twice in the first 24 hours and then once daily for a usual course of roughly 5 to 14 sessions. Up to about 30 sessions may be used for severe burns or staged reconstruction, with the exact course set by the hyperbaric physician alongside the burn team. Throughout, resuscitation, surgical assessment, and wound management remain the primary treatment, and hyperbaric oxygen is added around them.

The Canadian referral pathway

Severe thermal burn injury is publicly funded in Canada as one of the 14 conditions for which provincial health insurance covers HBOT at hospital-based programmes. In practice, adjunctive HBOT for burns is only available where a hyperbaric programme is co-located with or accessible to a burn centre, so the referral pathway runs through burn-centre transfer first.

  • Ontario: burn referrals route to the Ross Tilley Burn Centre at Sunnybrook (Toronto); Hamilton General Hospital also operates a hospital-based hyperbaric programme. CritiCall Ontario at 1-800-668-4357 coordinates emergency inter-hospital transfer and can arrange Ornge transport when needed.
  • British Columbia: route to Vancouver General Hospital, which has a hospital-based hyperbaric chamber; covered under MSP.
  • Alberta: burn care is anchored by the University of Alberta Hospital in Edmonton, with hospital-based hyperbaric treatment available at the Misericordia Community Hospital hyperbaric programme; covered by Alberta Health.
  • Quebec: RAMQ covers hospital-based hyperbaric programmes for recognised indications; coordinate burn transfer through the regional burn centre.
  • Provinces and territories without combined burn-and-HBOT capability: inter-provincial referral routes exist, with air-ambulance transfer to the nearest centre that can provide both burn care and hyperbaric treatment.

Because eligibility for adjunctive HBOT depends on the burn centre's assessment and on chamber availability, the practical step for a referring physician is to discuss the patient with the accepting burn centre and let that team coordinate any hyperbaric involvement.

Map of Canada marking burn and hyperbaric centres that coordinate adjunctive hyperbaric oxygen for thermal burns: Vancouver General Hospital in British Columbia, covered under MSP; the University of Alberta Hospital anchoring burn care and linked to the Misericordia Community Hospital hyperbaric programme in Alberta; the Ross Tilley Burn Centre at Sunnybrook in Toronto and Hamilton General Hospital in Ontario; regional burn-centre routing through RAMQ in Quebec; and inter-provincial air-ambulance routes for provinces without combined capability, with a callout that CritiCall Ontario at 1-800-668-4357 connects emergency departments to these centres.
Figure The Canadian referral pathway. For thermal burns, discuss the patient with the accepting burn centre first; that centre coordinates any hyperbaric involvement based on chamber availability. Centres with burn and hyperbaric capability include Vancouver General Hospital in British Columbia (covered under MSP), the University of Alberta Hospital in Edmonton with its linked Misericordia hyperbaric programme, the Ross Tilley Burn Centre at Sunnybrook in Toronto and Hamilton General Hospital in Ontario, and regional burn-centre routing through RAMQ in Quebec. Patients in provinces without combined burn and hyperbaric capability are moved by inter-provincial or air ambulance to the nearest centre. For urgent inter-hospital transfer in Ontario, CritiCall Ontario (1-800-668-4357) connects emergency departments to these centres.

Contraindications and cautions

The absolute contraindications relevant to the acute setting are an untreated pneumothorax, which must be drained before chamber entry, and concurrent bleomycin or concurrent disulfiram therapy. Relative cautions include severe haemodynamic instability requiring continuous high-dose vasopressor titration, an uncontrolled seizure disorder, and severe chronic obstructive pulmonary disease with bullous lung disease. In the burn patient specifically, adequate resuscitation, a secured airway, and exclusion of an undrained pneumothorax are practical prerequisites for safe treatment, and the burn centre and hyperbaric team should weigh these together before any session.

Safety matrix showing that adequate resuscitation and exclusion of an undrained pneumothorax are prerequisites for chamber entry. For each burn type, namely deep partial-thickness over 20 percent, full-thickness with stasis, and electrical, a haemodynamically stable patient is a referral candidate, an untreated pneumothorax requires intervention first, and a history of concurrent bleomycin or disulfiram is an absolute contraindication.
Figure Contraindications and cautions, screened before chamber entry. Adequate resuscitation and exclusion of an undrained pneumothorax are absolute prerequisites for safe treatment: a haemodynamically stable patient with a qualifying burn is a referral candidate, an untreated pneumothorax must be drained before any session, and concurrent bleomycin or disulfiram is an absolute contraindication. These rules apply equally across deep partial-thickness, full-thickness with stasis, and electrical burns. Relative cautions, including severe haemodynamic instability requiring high-dose vasopressors, uncontrolled seizures, and severe COPD with bullae, are weighed with the hyperbaric team but should not delay the initial referral conversation.

How to use the research list below

The list contains every thermal burn study in the Canada Hyperbarics database that was published in 2020 or later and has a freely available full-text version, each linked directly to that full text. Paywalled and abstract-only studies are excluded, and retracted studies are removed. This is a reference list, not a set of summaries. Because the open-access burn literature since 2020 is small, the list is short by design. Counts and the open-access set refresh each quarter.

Open-access research, 2020 to present

3 studies with a free full-text version, grouped by year, newest first. Each entry links to the full text. The set refreshes each quarter; retracted and paywalled studies are excluded.

20261 study
  1. Sah R et al. Role of hyperbaric oxygen therapy in oral submucous fibrosis: a randomized comparative study from India. Arch Craniofac Surg. Full text (Unpaywall) ›
20251 study
  1. Chu XL et al. Research progress in different physical therapies for treating peripheral nerve injuries. Frontiers in neurology. Full text (Unpaywall) ›
20211 study
  1. Alyafi T et al. Therapeutic Outcome of Burn Patients Treated With Hyperbaric Oxygen. Cureus. Full text (Unpaywall) ›

See also the condition overview: Thermal Burns.